In trading on Thursday, shares of John Wiley & Sons Inc. (Symbol: WLY) crossed above their 200 day moving average of $33.64, changing hands as high as $37.20 per share. John Wiley & Sons Inc. shares are currently trading up about 11.8% on the day. The chart below shows
In trading on Thursday, shares of Koninklijke Philips NV (Symbol: PHG) crossed above their 200 day moving average of $20.93, changing hands as high as $21.05 per share. Koninklijke Philips NV shares are currently trading up about 2.6% on the day. The chart below shows the one
Wall Street charged ahead on Thursday, with the S&P 500 posting a record closing high, with the biggest boosts from technology and growth stocks on investor optimism about prospects for rate cuts from the Federal Reserve.
How our income taxes are calculated is a mystery to the vast number of Americans who never learned to read the tax codes or decipher tax terminology from any class in school. Start, for example, with...
Below is Validea's guru fundamental report for AGNC INVESTMENT CORP (AGNC). Of the 22 guru strategies we follow, AGNC rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to shareh
Below is Validea's guru fundamental report for VF CORP (VFC). Of the 22 guru strategies we follow, VFC rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to shareholders via divi
Below is Validea's guru fundamental report for MAPLEBEAR INC (CART). Of the 22 guru strategies we follow, CART rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that have low P/B and P/
Below is Validea's guru fundamental report for CANADIAN NATIONAL RAILWAY CO (CNI). Of the 22 guru strategies we follow, CNI rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks t
Below is Validea's guru fundamental report for DTE ENERGY CO (DTE). Of the 22 guru strategies we follow, DTE rates highest using our Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings
(RTTNews) - Retailer BJ's Wholesale Club Holdings, Inc. (BJ) announced Thursday that net income for the fourth quarter grew to $145.87 million or $1.06 per share from $129.78 million or $0.95 per share in the prior-year quarter.
For many Americans, amassing a $1 million retirement nest egg is the ultimate dream. However, by and large, American investment accounts are falling short. As of 2023, the average retiree had just...
Spotify (NYSE: SPOT) has had an uphill battle against Apple (NASDAQ: AAPL) from the start, fighting against an integrated music service that had an inherent cost advantage. Yet, Spotify has more market share in music than Apple and now Europe is imposing a $2 billion fine against
When tech giant Nvidia disclosed its investments in a recent filing, it sent shares of tech stocks Arm Holdings and SoundHound AI (NASDAQ: SOUN) soaring. Year to date, both of these stocks are up over 80%, which is even better than Nvidia's gains thus far.
The automobile market is going through something of a renaissance right now. Car manufacturers worldwide are investing significant sums into battery-powered vehicles -- perhaps the bedrock of the green energy movement.
Telecom Italia (TIM) shares fell sharply on Thursday after the former phone monopoly unveiled its three-year outlook under a reshaped structure stemming from a network sale, with analysts citing lingering concerns over the debt level.
General Electric Co's aerospace business on Thursday reaffirmed its outlook for the current year and forecast a $10 billion of operating profit in 2028, citing robust demand for its products and services.
The stock market has slowly started to come to its senses about telecom giant AT&T (NYSE: T). While the stock is still down significantly from its all-time high, shares have surged around 25% since they bottomed out in mid-2023.
GSK said on Thursday a study showed its experimental drug Blenrep helped extend survival in patients with a type of blood cancer without symptoms worsening, marking a potential comeback for the drug after several setbacks.